At the Plenary Session of this year’s ASCO Annual Meeting, the results of a longitudinal trial begun in 2007 showed me that patient engagement is much more important that I had imagined.
We’re making progress in better understanding, and communicating, the many issues surrounding adverse events, although not as fast as we’d like. In the long run, our patients will benefit from all of these...